COLLAMEND FM IMPLANT

K082687 · C.R. Bard, Inc. · FTM · Oct 17, 2008 · General, Plastic Surgery

Device Facts

• Record ID: K082687
• Device Name: COLLAMEND FM IMPLANT
• Applicant: C.R. Bard, Inc.
• Product Code: FTM · General, Plastic Surgery
• Decision Date: Oct 17, 2008
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 878.3300
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The CollaMend FM Implant is indicated to reinforce soft tissue where weakness exists, e.g., for repair of hernia and chest wall defects, and for the surgical repair of damaged or ruptured soft tissue membranes.

Device Story

Sterile, fenestrated, lyophilized sheet of acellular porcine dermal collagen and elastin fibers; used as surgical mesh. Implanted by surgeons in clinical settings to reinforce soft tissue defects. Fenestrations facilitate cellular infiltration and host tissue replacement. Device requires rehydration in sterile saline or lactated Ringer's solution for at least 3 minutes prior to implantation. Provides structural support for hernia and chest wall repairs; promotes tissue ingrowth.

Clinical Evidence

No clinical data. Substantial equivalence supported by biocompatibility testing performed on the predicate CollaMend Implant and the identical nature of the source materials.

Technological Characteristics

Lyophilized, acellular porcine dermal collagen and elastin fibers. Flexible flat sheet, ~1 mm thick. Fenestrated design. Sterilized via Ethylene Oxide. Requires rehydration in sterile saline or lactated Ringer's solution.

Indications for Use

Indicated for reinforcement of soft tissue where weakness exists, including repair of hernia and chest wall defects, and surgical repair of damaged or ruptured soft tissue membranes.

Regulatory Classification

Identification

Surgical mesh is a metallic or polymeric screen intended to be implanted to reinforce soft tissue or bone where weakness exists. Examples of surgical mesh are metallic and polymeric mesh for hernia repair, and acetabular and cement restrictor mesh used during orthopedic surgery.

Predicate Devices

• Bard CollaMend Implant (Davol, Inc.)
• SIS Hernia Repair Device (Cook Medical)

Submission Summary (Full Text)

{0}------------------------------------------------

K082657
pore 1 of 3

## SECTION 7.0

510(K) SUMMARY OF SAFETY AND EFFECTIVENESS FOR THE COLLAMEND FM IMPLANT

OCT 1 7 2008

#### Submitter Information A.

| Submitter's Name: | Davol Inc. |
|----------------------|--------------------------------------------------------------------------------|
| Address: | Subsidiary of C. R. Bard, Inc.<br>100 Crossings Boulevard<br>Warwick, RI 02886 |
| Telephone: | [phone] |
| Fax: | [phone] |
| Contact Person: | Kevin G. Stevens |
| Date of Preparation: | Friday, September 12, 2008 |

#### B. Device Name

| Trade Name: | CollaMend FM Implant |
|----------------------|----------------------|
| Common/Usual Name: | Surgical Mesh |
| Classification Name: | Surgical Mesh |

#### C. Predicate Device Name

Bard CollaMend Implant (Davol, Inc.) Trade name:

SIS Hernia Repair Device (Cook Medical) Trade name:

#### D. Device Description

The proposed device is a sterile, fenestrated, off-white sheet of lyophilized, acellular porcine dermal collagen and its constituent elastin fibers. It is processed to remove all non-collagenous cellular components and is cross-linked to increase strength and endurance. The proposed device allows cellular infiltration via fenestrations and replacement by host tissue, forming a strong repair of soft tissue defects. The proposed device will be made available in various sizes and shapes, ranging from a 4" x 6" ellipse to a 10" x 14" rectangle. The thickness of the devices will be approximately 1 mm. Surgeons will need to rehydrate the product before implanting it into the patient. The proposed device will be marketed as a sterile, single use device.

#### E. Intended Use

PREMARKET NOTIFICATION FOR THE COLLAMEND FM IMPLANT

{1}------------------------------------------------

The CollaMend FM Implant is indicated to reinforce soft tissue where weakness exists, e.g., for repair of hernia and chest wall defects, and for the surgical repair of damaged or ruptured soft tissue membranes.

### Summary of Similarities and Differences in Technological F. Characteristics, Performance and Intended Use

The proposed device and the predicate CollaMend Implant differ only in design with CollaMend FM Implant having a pre-determined pattern of holes throughout the implant to allow for a more convenient pathway for tissue ingrowth in-vivo. The fenestrations allow for cellular infiltration. The "FM" in the name CollaMend FM Implant stands for fenestrated matrix.

The proposed device follows the same current manufacturing process as the predicate CollaMend Implant until the final manufacturing step (die cutting). At this point the fenestrations are added while simultaneously the device is cut to size. All other processes before and after this manufacturing step are identical. This results in a fenestrated implant similar to the predicate SIS Hernia Repair Device (Cook Medical).

The proposed device and both predicates are manufactured from animal (porcine) tissue materials. The proposed device and predicate CollaMend Implant are manufactured from acellular porcine dermis collagen. SIS Hernia Repair Device is manufactured from porcine intestinal collagen. All three devices are flexible flat sheets of material and are available in a variety of sizes and/or shapes.

The proposed device and the predicate CollaMend Implant are lyophilized before sterilization (Ethylene Oxide). Before use, both must be completely hydrated by immersion in sterile saline solution or sterile lactated Ringer's solution for a minimum of 3 minutes or until the clinical deems appropriate for the application. SIS Hernia Repair Device requires a minimum of 10 minutes for rehydration.

#### G. Performance Data

Biocompatibility testing on the predicate CollaMend Implant has been completed. The biocompatibility test results show that the implant is nontoxic and non-sensitizing to biological tissues consistent with its intended use.

Given that the predicate CollaMend Implant and proposed CollaMend FM Implant are manufactured from the same source material and are identical

{2}------------------------------------------------

K082687
pase 3 of 3

aside from the presence of fenestrations throughout the implant, no further biocompatibility testing was performed. The performance data provided clearly demonstrates that CollaMend FM Implant is substantially equivalent to CollaMend Implant and/or SIS Hernia Repair Device.

PREMARKET NOTIFICATION FOR THE COLLAMEND FM IMPLANT

{3}------------------------------------------------

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized caduceus, a symbol often associated with medicine and healthcare, with three intertwined strands. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES · USA" is arranged in a circular fashion around the symbol.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

OCT 1 7 2008

C.R. Bard, Inc. % Mr. Kevin G. Stevens Sr. Regulatory Affairs Associate 100 Crossings Boulevard Warwick, Rhode Island 02886

Re: K082687

Trade/Device Name: CollaMend FM Implant Regulation Number: 21 CFR 878.3300 Regulation Name: Surgical mesh Regulatory Class: II Product Code: FTM Dated: September 12, 2008 Received: September 15, 2008

Dear Mr. Stevens:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{4}------------------------------------------------

Page 2 - Mr. Kevin G. Stevens

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at [phone]. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at [phone]. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Mark M. Wilkerson

Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

## Indications for Use

510(k) Number (if known):

K08 2687

Device Name:

# CollaMend FM Implant

Indications for Use:

The CollaMend FM Implant is indicated to reinforce soft tissue where weakness exists, e.g., for repair of hernia and chest wall defects, and for the surgical repair of damaged or ruptured soft tissue membranes.

Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off) Division of General, Restorative, and Neurological Devices

**510(k) Number** K082687

Page 1 of 1